...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What Monday Brings?

"....I know many are hoping that they are going forward with the IPO/company split. I can't see it happening until there is some reason to compel people to buy, not sell, this stock...."

I don't think anyone is (should be) expecting a listing without events to boost the stock. Over the past year, Don has made it clear that they would want to time it with some major event such as a partnership deal, or a license deal, etc. And that they would do a reverse takeover rather than an IPO.

Share
New Message
Please login to post a reply